PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard (FR0011464452 – ALSGD), an innovative medical device company focused on improving spine surgery safety, announced today that the anticipation of pedicle breaches using its FDA-cleared and CE-marked PediGuard® device in a prospective clinical analysis of 50 patients with “rather rare and severe cervical spine disease” was 100% accurate in identifying an impassable cortical pedicle isthmus in 34 pedicles. The data was presented by principal investigator Heiko Koller, MD, PhD, at the 5th Annual Meeting of CSRS-AP in Ho Chi Minh City, Vietnam. In 34 pedicles a decision to stop pedicle screw tract preparation based on a signal from the PediGuard device that suggested an impassable cortical stimulus isthmus was later confirmed appropriate based on analysis of postoperative CT scans.
Help employers find you! Check out all the jobs and post your resume.
